ROYALTY PHARMA PLC- CL A (RPRX) Stock Cash Flow
NASDAQ:RPRX - Nasdaq - GB00BMVP7Y09 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Change In Working Capital | 57.88M | 38.43M | -113.00M | -213.30M | -11.70M | |||
| Interest Paid | -159.57M | -169.17M | -170.10M | -130.40M | -103.20M | |||
| OPERATING CASH FLOW | 2.77B | 2.99B | 2.14B | 2.02B | 2.03B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.51B | -2.12B | -1.74B | -2.19B | -2.18B | |||
| Other Investing Activity | -172.41M | 42.73M | 712.20M | 321.20M | -577.10M | |||
| INVESTING CASH FLOW | -2.68B | -2.07B | -1.03B | -1.87B | -2.76B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.47B | -1.00B | 0.00 | 1.27B | 680.60M | |||
| Stock Issued/Repurchased | -229.65M | -304.76M | 0.00 | 0.00 | 1.91B | |||
| Dividend Paid | -376.46M | -358.33M | -333.30M | -285.20M | -112.50M | |||
| Other Financing Activity | -503.97M | -485.67M | -611.50M | -602.20M | -989.70M | |||
| FINANCING CASH FLOW | 361.14M | -2.15B | -944.90M | 385.10M | 1.49B | |||
| CHANGE IN CASH | 452.02M | -1.23B | 169.70M | 532.30M | 762.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 2.77B | 2.99B | 2.14B | 2.02B | 2.03B | |||
| Capital Expenditure | -2.51B | -2.12B | -1.74B | -2.19B | -2.18B | |||
| FREE CASH FLOW | 263.29M | 872.28M | 402.40M | -174.00M | -147.60M | |||
All data in USD